Retrospective Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 6, 2022; 10(31): 11371-11380
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11371
Dynamic changes of estimated glomerular filtration rate are conversely related to triglyceride in non-overweight patients
Si-Qi Liu, Xiu-Jun Zhang, Yuan Xue, Rui Huang, Jian Wang, Chao Wu, Yi-Shan He, Ya-Ru Pan, Long-Gen Liu
Si-Qi Liu, Yi-Shan He, Ya-Ru Pan, Changzhou Clinical Medical College, Nanjing Medical University, Changzhou 213000, Jiangsu Province, China
Xiu-Jun Zhang, Yuan Xue, Long-Gen Liu, Institute of Hepatology, The Third People’s Hospital of Changzhou, Changzhou 213000, Jiangsu Province, China
Rui Huang, Jian Wang, Chao Wu, Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing 210008, Jiangsu Province, China
Author contributions: Liu LG, Wu C, and Xue Y desiged the study; Liu SQ, Xue Y, Huang R, Wang J, Pan YR, and He YS contributed data collection; Liu SQ, Xue Y, Pan YR, and He YS performed the data analysis; Liu SQ, Zhang XJ, and Xue Y drafted the manuscript; All authors read and approved the final manuscript.
Supported by the 333 High-Level Talents Project of Jiangsu Province, No. LGY2020032; the Science and Technology Project of Changzhou, No. CJ20200057; Qingmiao Talents Cultivation Project of Changzhou Health Commission, No. CZQM2020089.
Institutional review board statement: The study was approved by the Ethics Committee of the Third People’s Hospital of Changzhou according to the Declaration of Helsinki 1975.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors declare no conflicts of interest for this article.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at czsykjk@163.com. Participants gave informed consent for data sharing.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Long-Gen Liu, MD, Chief Doctor, Dean, Doctor, Professor, Institute of Hepatology, The Third People’s Hospital of Changzhou, No. 300 Lanling North Road, Changzhou 213000, Jiangsu Province, China. ssewllg@163.com
Received: August 1, 2022
Peer-review started: August 1, 2022
First decision: August 22, 2022
Revised: August 30, 2022
Accepted: September 23, 2022
Article in press: September 23, 2022
Published online: November 6, 2022
Abstract
BACKGROUND

Correlation between Triglyceride (TG) and estimated glomerular filtration rate (eGFR) remains largely unknown in overweight and non-overweight patients.

AIM

To investigated the dynamic changes of eGFR and lipid profiles during 3-year tenofovir disoproxil fumarate (TDF) treatment in patients with chronic hepatitis B (CHB) and overweight.

METHODS

A total of 202 CHB patients who received TDF treatment at the Third People's Hospital of Changzhou (Changzhou, China) and Nanjing Drum Tower Hospital (Nanjing, China) between January 2016 and May 2018 were retrospectively enrolled. According to the body mass index (BMI) at the initiation of TDF treatment, CHB patients were divided into overweight (BMI ≥ 25 kg/m2) and non-overweight (BMI < 25 kg/m2) groups. Logistic regression was applied for the analysis of risk factors for eGFR < 90 mL/(min·1.73 m2).

RESULTS

There is no significant difference in hepatitis B virus DNA (HBV DNA) negativity and hepatitis Be antigen (HBeAg) loss between patients with overweight and non-overweight (both P > 0.05). More patients in non-overweight group achieved alanine aminotransferase normalization compared with those in overweight group (χ2 = 11.036, P < 0.01). In non-overweight patients, the eGFR significantly declined in the 1st year (P < 0.01), then remained at a relatively lower level. TG significantly declined in the 2nd year (P = 0.02) and increased in the 3rd year. Moreover, TG was negatively correlated with GFR at the four-time points (P = 0.002, 0.030, 0.007, 0.008, respectively). In overweight patients, eGFR and TG remained relatively stable during the 3-year treatment, and eGFR showed no significant relationship with TG. Moreover, multivariate analysis showed that age [P < 0.01, 95%CI (0.97-1.005)] and baseline eGFR [P < 0.01, 95%CI (5.056-33.668)] were independent risk factors for eGFR < 90 mL/(min·1.73 m2) at the 3rd year.

CONCLUSION

Dynamic changes in renal function were conversely related to TG during TDF treatment in patients with CHB and normal BMI, but not with overweight.

Keywords: Tenofovir disoproxil fumarate, Hepatitis B virus, Glomerular filtration rate, Overweight, Body mass index

Core Tip: Correlation between Triglyceride (TG) and estimated glomerular filtration rate (eGFR) remains largely unknown. Our study indicated that more patients in non-overweight group achieved alanine aminotransferase normalization compared with those in overweight group (χ2 = 11.036, P < 0.01). In non-overweight patients, TG was negatively correlated with GFR at the four-time points (P = 0.002, 0.030, 0.007, 0.008, respectively). Dynamic changes in renal function were conversely related to TG during TDF treatment in patients with CHB and normal BMI, but not with overweight. Age [P < 0.01, 95%CI (0.97–1.005)] and baseline eGFR [P < 0.01, 95%CI (5.056–33.668)] were independent risk factors for eGFR < 90 mL/(min·1.73 m2) at the 3rd year.